Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-2019 | 10-2018 | 10-2017 | 10-2016 | 10-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,612 | -66,515 | -93,435 | -73,556 | -47,031 |
| Depreciation Amortization | 1,483 | 1,495 | 1,305 | 789 | 326 |
| Accounts receivable | 1,664 | -153 | N/A | N/A | N/A |
| Other Working Capital | -24,413 | -2,360 | -12,926 | 40,220 | 1,028 |
| Other Operating Activity | 1,750 | 5,404 | 28,214 | 23,404 | 21,513 |
| Operating Cash Flow | $-36,128 | $-62,129 | $-76,842 | $-9,144 | $-24,164 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 46,404 | -7,247 | 6,005 | -45,655 |
| PPE Investments | 29 | -1,425 | -3,449 | -3,222 | -973 |
| Purchase Sale Intangibles | -1,227 | -1,416 | -1,173 | -1,227 | -822 |
| Other Investing Activity | -1,227 | -1,416 | -1,760 | -1,227 | -822 |
| Investing Cash Flow | $-1,198 | $43,563 | $-12,456 | $1,556 | $-47,450 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 24,572 | 39,298 | 827 | 55,880 | 120,962 |
| Common Stock Repurchased | N/A | N/A | N/A | 73 | 29 |
| Other Financing Activity | -1 | -101 | -380 | -2,176 | -422 |
| Financing Cash Flow | $24,571 | $39,197 | $447 | $53,777 | $120,569 |
| Beginning Cash Position | 45,118 | 24,487 | 112,751 | 66,562 | 17,607 |
| End Cash Position | 32,363 | 45,118 | 23,900 | 112,751 | 66,562 |
| Net Cash Flow | $-12,755 | $20,631 | $-88,851 | $46,189 | $48,955 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,128 | -62,129 | -76,842 | -9,144 | -24,164 |
| Capital Expenditure | -54 | -1,425 | -3,449 | -3,222 | -973 |
| Free Cash Flow | -36,182 | -63,554 | -80,291 | -12,366 | -25,137 |